Sep 16, 2022 / 07:15AM GMT
Graham Glyn Charles Parry - BofA Securities, Research Division - MD and Head of Healthcare Equity Research
Thanks, everybody. Thanks for joining us this morning and making it to the third company day, fourth day overall of the conference here at Bank of America. So it's my pleasure to introduce the first session. We've got Emma Walmsley, CEO of GlaxoSmithKline. Also sitting in the front row here, also, Iain, the CFO as well.
I think probably the best thing is, Emma, if you want to make some opening remarks, and then we'll dive straight into Q&A. As a reminder, if you've got a question, please raise your hand and just wait for the microphone, but I've got plenty otherwise. So over to you, Emma.
Emma Natasha Walmsley - GSK plc - CEO & Director
No doubt. Well, thank you very much for having me, and a big thank you to those of you knowing that you can access all of this online. It's pretty good to see you and it's Friday, so thanks for coming in this morning.
Just a few opening remarks. Obviously, GSK has been through an enormous change
GSK plc at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers